Overview

18F F-AraG-PET Imaging to Evaluate Immunological Response CKI Therapy in Solid Tumors Imaging

Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is A pilot study of using [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Fluorides